A new onset of systemic lupus erythematosus developed after bee venom therapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rho, Young Hee | - |
dc.contributor.author | Woo, Jin-Hyun | - |
dc.contributor.author | Choi, Seong Jae | - |
dc.contributor.author | Lee, Young Ho | - |
dc.contributor.author | Ji, Jong Dae | - |
dc.contributor.author | Song, Gwan Gyu | - |
dc.date.available | 2021-01-06T00:40:17Z | - |
dc.date.issued | 2009-09 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.issn | 2005-6648 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/43723 | - |
dc.description.abstract | Lupus is a systemic autoimmune disease of an unknown origin, and systemic lupus erythematosus (SLE) can be triggered by numerous stimuli. Bee venom therapy is an alternative therapy that is believed to be effective for various kinds of arthritis. We present here a case of a 49-year-old female who experienced a new onset lupus after undergoing bee venom therapy, and this looked like a case of angioedema. The patient was successfully treated with high dose steroids and antimalarial drugs. We discuss the possibility of bee venom contributing to the development of SLE, and we suggest that such treatment should be avoided in patients with lupus. | - |
dc.format.extent | 3 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Korean Association of Internal Medicine/Daihan Naigwa Haghoi | - |
dc.title | A new onset of systemic lupus erythematosus developed after bee venom therapy | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3904/kjim.2009.24.3.283 | - |
dc.identifier.scopusid | 2-s2.0-70449721129 | - |
dc.identifier.bibliographicCitation | Korean Journal of Internal Medicine, v.24, no.3, pp 283 - 285 | - |
dc.citation.title | Korean Journal of Internal Medicine | - |
dc.citation.volume | 24 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 283 | - |
dc.citation.endPage | 285 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001375082 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | bee venom | - |
dc.subject.keywordPlus | fluconazole | - |
dc.subject.keywordPlus | hydroxychloroquine | - |
dc.subject.keywordPlus | methylprednisolone | - |
dc.subject.keywordPlus | prednisolone | - |
dc.subject.keywordPlus | bee venom | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | angioneurotic edema | - |
dc.subject.keywordPlus | arthritis | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | case report | - |
dc.subject.keywordPlus | delirium | - |
dc.subject.keywordPlus | drug megadose | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | hay fever | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | pancytopenia | - |
dc.subject.keywordPlus | systemic lupus erythematosus | - |
dc.subject.keywordPlus | thrush | - |
dc.subject.keywordPlus | urinary tract infection | - |
dc.subject.keywordPlus | middle aged | - |
dc.subject.keywordPlus | pathology | - |
dc.subject.keywordPlus | systemic lupus erythematosus | - |
dc.subject.keywordPlus | Bee Venoms | - |
dc.subject.keywordPlus | Female | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Lupus Erythematosus, Systemic | - |
dc.subject.keywordPlus | Middle Aged | - |
dc.subject.keywordAuthor | Angioedema | - |
dc.subject.keywordAuthor | Bee venoms | - |
dc.subject.keywordAuthor | Lupus erythematosus, systemic | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.